{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:32:45Z","timestamp":1793338365735,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL169345"],"award-info":[{"award-number":["R01HL169345"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K24 HL150476"],"award-info":[{"award-number":["K24 HL150476"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL167974"],"award-info":[{"award-number":["R01HL167974"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL168188"],"award-info":[{"award-number":["R01HL168188"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"American Heart Association\/Harold Amos Medical Faculty Development Program"},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","award":["2022051"],"award-info":[{"award-number":["2022051"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s11606-024-09126-6","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T12:01:54Z","timestamp":1729857714000},"page":"756-763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Factors Associated with Lipoprotein(a) Testing Among Multiethnic Individuals"],"prefix":"10.1007","volume":"40","author":[{"given":"Sumeet","family":"Brar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramzi","family":"Dudum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Powell","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Sarraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latha","family":"Palaniappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5226-0723","authenticated-orcid":false,"given":"Fatima","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"issue":"7","key":"9126_CR1","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/jamacardio.2022.0987","volume":"7","author":"F Duarte Lau","year":"2022","unstructured":"Duarte Lau F, Giugliano RP. Lipoprotein(a) and its Significance in Cardiovascular Disease: A Review. JAMA Cardiol. 2022;7(7):760-769. https:\/\/doi.org\/10.1001\/jamacardio.2022.0987","journal-title":"JAMA Cardiol."},{"issue":"1","key":"9126_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-188. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455","journal-title":"Eur Heart J."},{"issue":"8","key":"9126_CR3","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.cjca.2021.03.016","volume":"37","author":"GJ Pearson","year":"2021","unstructured":"Pearson GJ, Thanassoulis G, Anderson TJ, et al. 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults. Can J Cardiol. 2021;37(8):1129-1150. https:\/\/doi.org\/10.1016\/j.cjca.2021.03.016","journal-title":"Can J Cardiol."},{"issue":"3","key":"9126_CR4","doi-asserted-by":"publisher","first-page":"e308","DOI":"10.1016\/j.jacl.2024.03.001","volume":"18","author":"ML Koschinsky","year":"2024","unstructured":"Koschinsky ML, Bajaj A, Boffa MB, et al. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol. 2024;18(3):e308-e319. https:\/\/doi.org\/10.1016\/j.jacl.2024.03.001","journal-title":"J Clin Lipidol."},{"issue":"25","key":"9126_CR5","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1161\/CIR.0000000000000625","volume":"139","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082-e1143. https:\/\/doi.org\/10.1161\/CIR.0000000000000625","journal-title":"Circulation."},{"issue":"18","key":"9126_CR6","doi-asserted-by":"publisher","first-page":"e031255","DOI":"10.1161\/JAHA.123.031255","volume":"12","author":"HS Bhatia","year":"2023","unstructured":"Bhatia HS, Hurst S, Desai P, Zhu W, Yeang C. Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States. J Am Heart Assoc. 2023;12(18):e031255. https:\/\/doi.org\/10.1161\/JAHA.123.031255","journal-title":"J Am Heart Assoc."},{"issue":"12","key":"9126_CR7","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1136\/oem.2004.014472","volume":"61","author":"DB Richardson","year":"2004","unstructured":"Richardson DB. An incidence density sampling program for nested case-control analyses. Occup Environ Med. 2004;61(12):e59. https:\/\/doi.org\/10.1136\/oem.2004.014472","journal-title":"Occup Environ Med."},{"issue":"2","key":"9126_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2307\/2531050","volume":"42","author":"JM Robins","year":"1986","unstructured":"Robins JM, Gail MH, Lubin JH. More on \u201cBiased selection of controls for case-control analyses of cohort studies.\u201d Biometrics. 1986;42(2):293-299.","journal-title":"Biometrics."},{"issue":"8","key":"9126_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573-577. https:\/\/doi.org\/10.7326\/0003-4819-147-8-200710160-00010","journal-title":"Ann Intern Med."},{"issue":"6","key":"9126_CR10","doi-asserted-by":"publisher","first-page":"100940","DOI":"10.1016\/j.jacadv.2024.100940","volume":"3","author":"R Dudum","year":"2024","unstructured":"Dudum R, Huang Q, Yan X (Sherry), et al. Lipoprotein(a) Levels in Disaggregated Racial and Ethnic Subgroups Across Atherosclerotic Cardiovascular Disease Risk Levels. JACC Adv. 2024;3(6):100940. https:\/\/doi.org\/10.1016\/j.jacadv.2024.100940","journal-title":"JACC Adv."},{"key":"9126_CR11","doi-asserted-by":"publisher","first-page":"100478","DOI":"10.1016\/j.ajpc.2023.100478","volume":"14","author":"MD Kelsey","year":"2023","unstructured":"Kelsey MD, Mulder H, Chiswell K, et al. Contemporary patterns of lipoprotein(a) testing and associated clinical care and outcomes. Am J Prev Cardiol. 2023;14:100478. https:\/\/doi.org\/10.1016\/j.ajpc.2023.100478","journal-title":"Am J Prev Cardiol."},{"key":"9126_CR12","doi-asserted-by":"publisher","first-page":"100476","DOI":"10.1016\/j.ajpc.2023.100476","volume":"14","author":"X Hu","year":"2023","unstructured":"Hu X, Cristino J, Gautam R, et al. Characteristics and lipid lowering treatment patterns in patients tested for lipoprotein(a): A real-world US study. Am J Prev Cardiol. 2023;14:100476. https:\/\/doi.org\/10.1016\/j.ajpc.2023.100476","journal-title":"Am J Prev Cardiol."},{"key":"9126_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.atherosclerosis.2023.01.014","volume":"367","author":"PE St\u00fcrzebecher","year":"2023","unstructured":"St\u00fcrzebecher PE, Schorr JJ, Klebs SHG, Laufs U. Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses. Atherosclerosis. 2023;367:24-33. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.01.014","journal-title":"Atherosclerosis."},{"issue":"3","key":"9126_CR14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jacl.2019.04.010","volume":"13","author":"DP Wilson","year":"2019","unstructured":"Wilson DP, Jacobson TA, Jones PH, et al. Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association. J Clin Lipidol. 2019;13(3):374-392. https:\/\/doi.org\/10.1016\/j.jacl.2019.04.010","journal-title":"J Clin Lipidol."},{"issue":"2","key":"9126_CR15","doi-asserted-by":"publisher","first-page":"e002060","DOI":"10.1136\/openhrt-2022-002060","volume":"9","author":"SE Nissen","year":"2022","unstructured":"Nissen SE, Wolski K, Cho L, et al. Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease. Open Heart. 2022;9(2):e002060. https:\/\/doi.org\/10.1136\/openhrt-2022-002060","journal-title":"Open Heart."},{"key":"9126_CR16","doi-asserted-by":"publisher","first-page":"291954","DOI":"10.1155\/2011\/291954","volume":"2011","author":"D Banerjee","year":"2011","unstructured":"Banerjee D, Wong EC, Shin J, Fortmann SP, Palaniappan L. Racial and Ethnic Variation in Lipoprotein (a) Levels among Asian Indian and Chinese Patients. J Lipids. 2011;2011:291954. https:\/\/doi.org\/10.1155\/2011\/291954","journal-title":"J Lipids."},{"key":"9126_CR17","doi-asserted-by":"publisher","unstructured":"Kwan TW, Wong SS, Hong Y, et al. Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association. Circulation. 0(0). https:\/\/doi.org\/10.1161\/CIR.0000000000001145","DOI":"10.1161\/CIR.0000000000001145"},{"key":"9126_CR18","doi-asserted-by":"publisher","unstructured":"Gulati RK, Husaini M, Dash R, Patel J, Shah NS. Clinical programs for cardiometabolic health for South Asian patients in the United States: A review of key program components. Health Sci Rev Oxf. 2023;7. https:\/\/doi.org\/10.1016\/j.hsr.2023.100093","DOI":"10.1016\/j.hsr.2023.100093"},{"issue":"4","key":"9126_CR19","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1161\/ATVBAHA.114.304785","volume":"35","author":"W Guan","year":"2015","unstructured":"Guan W, Cao J, Steffen BT, et al. Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35(4):996-1001. https:\/\/doi.org\/10.1161\/ATVBAHA.114.304785","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"9","key":"9126_CR20","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/oxfordjournals.aje.a116571","volume":"136","author":"SM Haffner","year":"1992","unstructured":"Haffner SM, Gruber KK, Morales PA, et al. Lipoprotein(a) Concentrations in Mexican Americans and Non-Hispanic Whites: The San Antonio Heart Study. Am J Epidemiol. 1992;136(9):1060-1068. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a116571","journal-title":"Am J Epidemiol."},{"issue":"12","key":"9126_CR21","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.118.034311","volume":"139","author":"G Par\u00e9","year":"2019","unstructured":"Par\u00e9 G, \u00c7aku A, McQueen M, et al. Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups. Circulation. 2019;139(12):1472-1482. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034311","journal-title":"Circulation."},{"issue":"5","key":"9126_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.18553\/jmcp.2023.29.5.519","volume":"29","author":"AF Fonseca","year":"2023","unstructured":"Fonseca AF, Byrne H, Laguna A, et al. Burden of lipoprotein(a) for patients with atherosclerotic cardiovascular disease: A retrospective analysis from the United States. J Manag Care Spec Pharm. 2023;29(5):519-529. https:\/\/doi.org\/10.18553\/jmcp.2023.29.5.519","journal-title":"J Manag Care Spec Pharm."},{"key":"9126_CR23","unstructured":"O\u2019Connor A. A Heart Risk Factor Even Doctors Know Little About. The New York Times. https:\/\/www.nytimes.com\/2018\/01\/09\/well\/heart-risk-doctors-lipoprotein.html. Published January 9, 2018. Accessed January 27, 2023."},{"key":"9126_CR24","unstructured":"Centers for Medicare & Medicaid Services. MolDX: Biomarkers in Cardiovascular Risk Assessment. Medicare Coverage Database. https:\/\/www.cms.gov\/medicare-coverage-database\/view\/lcd.aspx?LCDId=36358.\u00a0Accessed 7\/2\/2024."},{"key":"9126_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.amjcard.2021.05.018","volume":"153","author":"M Kelsey","year":"2021","unstructured":"Kelsey M, Page C, Alhanti B, et al. Lipoprotein(a) Testing Patterns in a Large Health System. Am J Cardiol. 2021;153:43-50. https:\/\/doi.org\/10.1016\/j.amjcard.2021.05.018","journal-title":"Am J Cardiol."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-09126-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-024-09126-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-09126-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:09:38Z","timestamp":1764266978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-024-09126-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["9126"],"URL":"https:\/\/doi.org\/10.1007\/s11606-024-09126-6","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]},"assertion":[{"value":"14 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"Dr. Rodriguez reports equity from Carta Healthcare and HealthPals, and consulting fees from HealthPals, Novartis, NovoNordisk, Esperion Therapeutics, Movano Health, Kento Health, Inclusive Health, Edwards, Arrowhead Pharmaceuticals, HeartFlow, iRhythm, Amgen, and Cleerly Health outside the submitted work. The remaining authors report no relevant disclosures or competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}